Mitochondria integrate metabolic networks for maintaining bioenergetic requirements. Deregulation of mitochondrial metabolic networks can lead to
mitochondrial dysfunction, which is a common hallmark of many diseases. Reversible post-translational
protein acetylation modifications are emerging as critical regulators of mitochondrial function and form a direct link between metabolism and
protein function, via the metabolic intermediate
acetyl-CoA.
Sirtuins catalyze
protein deacetylation, but how mitochondrial acetylation is determined is unclear. We report here a mechanism that explains
mitochondrial protein acetylation dynamics in vivo. Food withdrawal in mice induces a rapid increase in hepatic
protein acetylation. Furthermore, using a novel LC-MS/MS method, we were able to quantify
protein acetylation in human fibroblasts. We demonstrate that inducing
fatty acid oxidation in fibroblasts increases
protein acetylation. Furthermore, we show by using radioactively labeled
palmitate that
fatty acids are a direct source for
mitochondrial protein acetylation. Intriguingly, in a mouse model that resembles human
very-long chain acyl-CoA dehydrogenase (
VLCAD) deficiency, we demonstrate that upon food-withdrawal, hepatic
protein hyperacetylation is absent. This indicates that functional
fatty acid oxidation is necessary for
protein acetylation to occur in the liver upon food withdrawal. Furthermore, we now demonstrate that
protein acetylation is abundant in human liver peroxisomes, an organelle where
acetyl-CoA is solely generated by
fatty acid oxidation. Our findings provide a mechanism for metabolic control of
protein acetylation, which provides insight into the pathophysiogical role of
protein acetylation dynamics in
fatty acid oxidation disorders and other
metabolic diseases associated with
mitochondrial dysfunction.